Advisor to Pharma-Vinci in the sale to Axellus
February 29, 2012
ATRIUM has advised the shareholders of Pharma-Vinci in connection with the sale to Axellus, owned by Orkla, which is listed on the Oslo Stock Exchange.
ATRIUM has advised the shareholders of Pharma-Vinci in connection with the sale to Axellus, owned by Orkla, which is listed on the Oslo Stock Exchange.
Pharma-Vinci is a Danish pharmaceutical company that develops, manufactures and markets products in dietary supplements, herbal remedies and OTC-pharmaceuticals.
Pharma-Vinci has focused on products in calcium deficiency and products for intimate care for women. The company owns, among others the market-leading brands UniKalk, Vivag, Canvag, Intima and BioVinci. Axellus take all Pharma-Vinci products into its Northern European distribution channel and expect significant sales.
ATRIUM has been in contact with most big pharma manufacturers, as well as a number of international OTC and VMS manufacturers.
Den betroede partner
Financial advisor to Wismo Group in the sale of Quickpoint to OGV
Financial advisor to BU Bregal Unternehmerkapital in the acquisition of SwipBox
Exclusive Financial Advisor to Rambøll in the acquisition of Envidan
Exclusive financial advisor to TestaViva in the sale to management and Dansk Ejerkapital
Financial advisor to BU Bregal Unternehmerkapital in the acquisition of Uniconta
Exclusive financial advisor to KN Helicopters in the sale to Avincis
Financial advisor to Bluestar PLM in the sale to Volpi Capital
Financial advisor to Spica Technology in the sale to Ernströmgruppen
Advisor to Quality Pellets in the sale to the Danish private equity firm, Executive Capital
Financial advisor to K.W. Bruun & Co in the sale of K.W. Bruun Import and K.W. Bruun NxT to Global Auto Holdings Limited
Shall we discuss
your opportunities?
Successful M&A processes are built on experience, trust, and chemistry. Therefore, let's start with a non-binding discussion of your opportunities.
ATRIUM Partners A/S
